ERS3565920 SAMEA5762474 9606 Homo sapiens Protocols: All patients were enrolled at Icahn School of Medicine at Mount Sinai (ISMMS) and provided informed consent for tissue biobanking. Samples were provided by the ISMMS Biorepository. All patients were diagnosed with hepatocellular carcinoma based on the EASL guidelines, and were treatment-naïve prior to surgical resection. The different regions were sampled allowing for at least 1 cm of distance between each other. The final number of regions per tumor varied according to tissue availability and presence of tumor necrosis. Each tumor and adjacent tissue sample was split in half to allow for mirrored histological and molecular analysis. Half of the sample was immediately stored in RNA-later (Qiagen) for 24 hours at 4°C, and subsequently at -80°C, and the other half was embedded in OCT and stored at -80°C. RNA was extracted from HCC samples using the RNeasy mini kit (Qiagen) following manufacturer's instructions. Performed by Mount Sinai core facility according to manufacturer's protocol. See protocol at https://support.illumina.com/sequencing/sequencing_kits/truseq_rna_sample_prep_kit_v2.html ENA-FIRST-PUBLIC 2019-07-18T04:03:34Z ENA-LAST-UPDATE 2019-07-08T14:37:01Z External Id SAMEA5762474 INSDC center name Icahn School of Medicine at Mount Sinai INSDC first public 2019-07-18T04:03:34Z INSDC last update 2019-07-08T14:37:01Z INSDC status public Submitter Id E-MTAB-59051562592668:H11.a age 61 broker name ArrayExpress common name human disease hepatocellular carcinoma individual 11 organism part liver sample name E-MTAB-59051562592668:H11.a sampling site primary neoplasm scientific_name Homo sapiens sex male ERS3565921 SAMEA5762475 9606 Homo sapiens Protocols: All patients were enrolled at Icahn School of Medicine at Mount Sinai (ISMMS) and provided informed consent for tissue biobanking. Samples were provided by the ISMMS Biorepository. All patients were diagnosed with hepatocellular carcinoma based on the EASL guidelines, and were treatment-naïve prior to surgical resection. The different regions were sampled allowing for at least 1 cm of distance between each other. The final number of regions per tumor varied according to tissue availability and presence of tumor necrosis. Each tumor and adjacent tissue sample was split in half to allow for mirrored histological and molecular analysis. Half of the sample was immediately stored in RNA-later (Qiagen) for 24 hours at 4°C, and subsequently at -80°C, and the other half was embedded in OCT and stored at -80°C. RNA was extracted from HCC samples using the RNeasy mini kit (Qiagen) following manufacturer's instructions. Performed by Mount Sinai core facility according to manufacturer's protocol. See protocol at https://support.illumina.com/sequencing/sequencing_kits/truseq_rna_sample_prep_kit_v2.html ENA-FIRST-PUBLIC 2019-07-18T04:03:34Z ENA-LAST-UPDATE 2019-07-08T14:37:01Z External Id SAMEA5762475 INSDC center name Icahn School of Medicine at Mount Sinai INSDC first public 2019-07-18T04:03:34Z INSDC last update 2019-07-08T14:37:01Z INSDC status public Submitter Id E-MTAB-59051562592668:H11.b age 61 broker name ArrayExpress common name human disease hepatocellular carcinoma individual 11 organism part liver sample name E-MTAB-59051562592668:H11.b sampling site primary neoplasm scientific_name Homo sapiens sex male ERS3565922 SAMEA5762476 9606 Homo sapiens Protocols: All patients were enrolled at Icahn School of Medicine at Mount Sinai (ISMMS) and provided informed consent for tissue biobanking. Samples were provided by the ISMMS Biorepository. All patients were diagnosed with hepatocellular carcinoma based on the EASL guidelines, and were treatment-naïve prior to surgical resection. The different regions were sampled allowing for at least 1 cm of distance between each other. The final number of regions per tumor varied according to tissue availability and presence of tumor necrosis. Each tumor and adjacent tissue sample was split in half to allow for mirrored histological and molecular analysis. Half of the sample was immediately stored in RNA-later (Qiagen) for 24 hours at 4°C, and subsequently at -80°C, and the other half was embedded in OCT and stored at -80°C. RNA was extracted from HCC samples using the RNeasy mini kit (Qiagen) following manufacturer's instructions. Performed by Mount Sinai core facility according to manufacturer's protocol. See protocol at https://support.illumina.com/sequencing/sequencing_kits/truseq_rna_sample_prep_kit_v2.html ENA-FIRST-PUBLIC 2019-07-18T04:03:34Z ENA-LAST-UPDATE 2019-07-08T14:37:01Z External Id SAMEA5762476 INSDC center name Icahn School of Medicine at Mount Sinai INSDC first public 2019-07-18T04:03:34Z INSDC last update 2019-07-08T14:37:01Z INSDC status public Submitter Id E-MTAB-59051562592668:N11 age 61 broker name ArrayExpress common name human disease hepatocellular carcinoma individual 11 organism part liver sample name E-MTAB-59051562592668:N11 sampling site normal tissue adjacent to neoplasm scientific_name Homo sapiens sex male ERS3565923 SAMEA5762477 9606 Homo sapiens Protocols: All patients were enrolled at Icahn School of Medicine at Mount Sinai (ISMMS) and provided informed consent for tissue biobanking. Samples were provided by the ISMMS Biorepository. All patients were diagnosed with hepatocellular carcinoma based on the EASL guidelines, and were treatment-naïve prior to surgical resection. The different regions were sampled allowing for at least 1 cm of distance between each other. The final number of regions per tumor varied according to tissue availability and presence of tumor necrosis. Each tumor and adjacent tissue sample was split in half to allow for mirrored histological and molecular analysis. Half of the sample was immediately stored in RNA-later (Qiagen) for 24 hours at 4°C, and subsequently at -80°C, and the other half was embedded in OCT and stored at -80°C. RNA was extracted from HCC samples using the RNeasy mini kit (Qiagen) following manufacturer's instructions. Performed by Mount Sinai core facility according to manufacturer's protocol. See protocol at https://support.illumina.com/sequencing/sequencing_kits/truseq_rna_sample_prep_kit_v2.html ENA-FIRST-PUBLIC 2019-07-18T04:03:34Z ENA-LAST-UPDATE 2019-07-08T14:37:01Z External Id SAMEA5762477 INSDC center name Icahn School of Medicine at Mount Sinai INSDC first public 2019-07-18T04:03:34Z INSDC last update 2019-07-08T14:37:01Z INSDC status public Submitter Id E-MTAB-59051562592668:H12.a age 68 broker name ArrayExpress common name human disease hepatocellular carcinoma individual 12 organism part liver sample name E-MTAB-59051562592668:H12.a sampling site primary neoplasm scientific_name Homo sapiens sex female ERS3565924 SAMEA5762478 9606 Homo sapiens Protocols: All patients were enrolled at Icahn School of Medicine at Mount Sinai (ISMMS) and provided informed consent for tissue biobanking. Samples were provided by the ISMMS Biorepository. All patients were diagnosed with hepatocellular carcinoma based on the EASL guidelines, and were treatment-naïve prior to surgical resection. The different regions were sampled allowing for at least 1 cm of distance between each other. The final number of regions per tumor varied according to tissue availability and presence of tumor necrosis. Each tumor and adjacent tissue sample was split in half to allow for mirrored histological and molecular analysis. Half of the sample was immediately stored in RNA-later (Qiagen) for 24 hours at 4°C, and subsequently at -80°C, and the other half was embedded in OCT and stored at -80°C. RNA was extracted from HCC samples using the RNeasy mini kit (Qiagen) following manufacturer's instructions. Performed by Mount Sinai core facility according to manufacturer's protocol. See protocol at https://support.illumina.com/sequencing/sequencing_kits/truseq_rna_sample_prep_kit_v2.html ENA-FIRST-PUBLIC 2019-07-18T04:03:34Z ENA-LAST-UPDATE 2019-07-08T14:37:01Z External Id SAMEA5762478 INSDC center name Icahn School of Medicine at Mount Sinai INSDC first public 2019-07-18T04:03:34Z INSDC last update 2019-07-08T14:37:01Z INSDC status public Submitter Id E-MTAB-59051562592668:H12.b age 68 broker name ArrayExpress common name human disease hepatocellular carcinoma individual 12 organism part liver sample name E-MTAB-59051562592668:H12.b sampling site primary neoplasm scientific_name Homo sapiens sex female ERS3565925 SAMEA5762479 9606 Homo sapiens Protocols: All patients were enrolled at Icahn School of Medicine at Mount Sinai (ISMMS) and provided informed consent for tissue biobanking. Samples were provided by the ISMMS Biorepository. All patients were diagnosed with hepatocellular carcinoma based on the EASL guidelines, and were treatment-naïve prior to surgical resection. The different regions were sampled allowing for at least 1 cm of distance between each other. The final number of regions per tumor varied according to tissue availability and presence of tumor necrosis. Each tumor and adjacent tissue sample was split in half to allow for mirrored histological and molecular analysis. Half of the sample was immediately stored in RNA-later (Qiagen) for 24 hours at 4°C, and subsequently at -80°C, and the other half was embedded in OCT and stored at -80°C. RNA was extracted from HCC samples using the RNeasy mini kit (Qiagen) following manufacturer's instructions. Performed by Mount Sinai core facility according to manufacturer's protocol. See protocol at https://support.illumina.com/sequencing/sequencing_kits/truseq_rna_sample_prep_kit_v2.html ENA-FIRST-PUBLIC 2019-07-18T04:03:34Z ENA-LAST-UPDATE 2019-07-08T14:37:01Z External Id SAMEA5762479 INSDC center name Icahn School of Medicine at Mount Sinai INSDC first public 2019-07-18T04:03:34Z INSDC last update 2019-07-08T14:37:01Z INSDC status public Submitter Id E-MTAB-59051562592668:H12.c age 68 broker name ArrayExpress common name human disease hepatocellular carcinoma individual 12 organism part liver sample name E-MTAB-59051562592668:H12.c sampling site primary neoplasm scientific_name Homo sapiens sex female ERS3565926 SAMEA5762480 9606 Homo sapiens Protocols: All patients were enrolled at Icahn School of Medicine at Mount Sinai (ISMMS) and provided informed consent for tissue biobanking. Samples were provided by the ISMMS Biorepository. All patients were diagnosed with hepatocellular carcinoma based on the EASL guidelines, and were treatment-naïve prior to surgical resection. The different regions were sampled allowing for at least 1 cm of distance between each other. The final number of regions per tumor varied according to tissue availability and presence of tumor necrosis. Each tumor and adjacent tissue sample was split in half to allow for mirrored histological and molecular analysis. Half of the sample was immediately stored in RNA-later (Qiagen) for 24 hours at 4°C, and subsequently at -80°C, and the other half was embedded in OCT and stored at -80°C. RNA was extracted from HCC samples using the RNeasy mini kit (Qiagen) following manufacturer's instructions. Performed by Mount Sinai core facility according to manufacturer's protocol. See protocol at https://support.illumina.com/sequencing/sequencing_kits/truseq_rna_sample_prep_kit_v2.html ENA-FIRST-PUBLIC 2019-07-18T04:03:34Z ENA-LAST-UPDATE 2019-07-08T14:37:01Z External Id SAMEA5762480 INSDC center name Icahn School of Medicine at Mount Sinai INSDC first public 2019-07-18T04:03:34Z INSDC last update 2019-07-08T14:37:01Z INSDC status public Submitter Id E-MTAB-59051562592668:H12.d age 68 broker name ArrayExpress common name human disease hepatocellular carcinoma individual 12 organism part liver sample name E-MTAB-59051562592668:H12.d sampling site primary neoplasm scientific_name Homo sapiens sex female ERS3565927 SAMEA5762481 9606 Homo sapiens Protocols: All patients were enrolled at Icahn School of Medicine at Mount Sinai (ISMMS) and provided informed consent for tissue biobanking. Samples were provided by the ISMMS Biorepository. All patients were diagnosed with hepatocellular carcinoma based on the EASL guidelines, and were treatment-naïve prior to surgical resection. The different regions were sampled allowing for at least 1 cm of distance between each other. The final number of regions per tumor varied according to tissue availability and presence of tumor necrosis. Each tumor and adjacent tissue sample was split in half to allow for mirrored histological and molecular analysis. Half of the sample was immediately stored in RNA-later (Qiagen) for 24 hours at 4°C, and subsequently at -80°C, and the other half was embedded in OCT and stored at -80°C. RNA was extracted from HCC samples using the RNeasy mini kit (Qiagen) following manufacturer's instructions. Performed by Mount Sinai core facility according to manufacturer's protocol. See protocol at https://support.illumina.com/sequencing/sequencing_kits/truseq_rna_sample_prep_kit_v2.html ENA-FIRST-PUBLIC 2019-07-18T04:03:34Z ENA-LAST-UPDATE 2019-07-08T14:37:01Z External Id SAMEA5762481 INSDC center name Icahn School of Medicine at Mount Sinai INSDC first public 2019-07-18T04:03:34Z INSDC last update 2019-07-08T14:37:01Z INSDC status public Submitter Id E-MTAB-59051562592668:H12.e age 68 broker name ArrayExpress common name human disease hepatocellular carcinoma individual 12 organism part liver sample name E-MTAB-59051562592668:H12.e sampling site primary neoplasm scientific_name Homo sapiens sex female ERS3565928 SAMEA5762482 9606 Homo sapiens Protocols: All patients were enrolled at Icahn School of Medicine at Mount Sinai (ISMMS) and provided informed consent for tissue biobanking. Samples were provided by the ISMMS Biorepository. All patients were diagnosed with hepatocellular carcinoma based on the EASL guidelines, and were treatment-naïve prior to surgical resection. The different regions were sampled allowing for at least 1 cm of distance between each other. The final number of regions per tumor varied according to tissue availability and presence of tumor necrosis. Each tumor and adjacent tissue sample was split in half to allow for mirrored histological and molecular analysis. Half of the sample was immediately stored in RNA-later (Qiagen) for 24 hours at 4°C, and subsequently at -80°C, and the other half was embedded in OCT and stored at -80°C. RNA was extracted from HCC samples using the RNeasy mini kit (Qiagen) following manufacturer's instructions. Performed by Mount Sinai core facility according to manufacturer's protocol. See protocol at https://support.illumina.com/sequencing/sequencing_kits/truseq_rna_sample_prep_kit_v2.html ENA-FIRST-PUBLIC 2019-07-18T04:03:34Z ENA-LAST-UPDATE 2019-07-08T14:37:01Z External Id SAMEA5762482 INSDC center name Icahn School of Medicine at Mount Sinai INSDC first public 2019-07-18T04:03:34Z INSDC last update 2019-07-08T14:37:01Z INSDC status public Submitter Id E-MTAB-59051562592668:N12.a age 68 broker name ArrayExpress common name human disease hepatocellular carcinoma individual 12 organism part liver sample name E-MTAB-59051562592668:N12.a sampling site normal tissue adjacent to neoplasm scientific_name Homo sapiens sex female ERS3565929 SAMEA5762483 9606 Homo sapiens Protocols: All patients were enrolled at Icahn School of Medicine at Mount Sinai (ISMMS) and provided informed consent for tissue biobanking. Samples were provided by the ISMMS Biorepository. All patients were diagnosed with hepatocellular carcinoma based on the EASL guidelines, and were treatment-naïve prior to surgical resection. The different regions were sampled allowing for at least 1 cm of distance between each other. The final number of regions per tumor varied according to tissue availability and presence of tumor necrosis. Each tumor and adjacent tissue sample was split in half to allow for mirrored histological and molecular analysis. Half of the sample was immediately stored in RNA-later (Qiagen) for 24 hours at 4°C, and subsequently at -80°C, and the other half was embedded in OCT and stored at -80°C. RNA was extracted from HCC samples using the RNeasy mini kit (Qiagen) following manufacturer's instructions. Performed by Mount Sinai core facility according to manufacturer's protocol. See protocol at https://support.illumina.com/sequencing/sequencing_kits/truseq_rna_sample_prep_kit_v2.html ENA-FIRST-PUBLIC 2019-07-18T04:03:34Z ENA-LAST-UPDATE 2019-07-08T14:37:01Z External Id SAMEA5762483 INSDC center name Icahn School of Medicine at Mount Sinai INSDC first public 2019-07-18T04:03:34Z INSDC last update 2019-07-08T14:37:01Z INSDC status public Submitter Id E-MTAB-59051562592668:N12.b age 68 broker name ArrayExpress common name human disease hepatocellular carcinoma individual 12 organism part liver sample name E-MTAB-59051562592668:N12.b sampling site normal tissue adjacent to neoplasm scientific_name Homo sapiens sex female